[Recent advances in the treatment of idiopathic thrombocytopenic purpura].
Kurata
Yoshiyuki
Y
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001565:Benzoates / Q000627:therapeutic use; D002352:Carrier Proteins / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007074:Immunoglobulin G / Q000008:administration & dosage; D010535:Laparoscopy; D017713:Platelet Transfusion; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000008:administration & dosage; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000628:therapy*; D011720:Pyrazoles / Q000627:therapeutic use; D011961:Receptors, Fc / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins; D000069283:Rituximab; D013156:Splenectomy; D013926:Thrombopoietin / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001565:Benzoates; D002352:Carrier Proteins; D006834:Hydrazines; D007074:Immunoglobulin G; D011720:Pyrazoles; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D000069283:Rituximab; D013926:Thrombopoietin; D011239:Prednisolone; C488777:romiplostim; C520809:eltrombopag